Home › Compare › HCLC vs NOBL

HCLC vs NOBL: Dividend Comparison 2026

HCLC yields 2000000.00% · NOBL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HCLC wins by $4.879226400974806e+39M in total portfolio value
10 years
HCLC
HCLC
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full HCLC calculator →
NOBL
NOBL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NOBL calculator →

Portfolio growth — HCLC vs NOBL

📍 HCLC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHCLCNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HCLC + NOBL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HCLC pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HCLC
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, HCLC beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HCLC + NOBL for your $10,000?

HCLC: 50%NOBL: 50%
100% NOBL50/50100% HCLC
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HCLC buys
0
NOBL buys
0
No recent congressional trades found for HCLC or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHCLCNOBL
Forward yield2000000.00% ✓4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR0%5% ✓
Portfolio after 10y$4.879226400974806e+39M$28.0K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$899.19
Total dividends collected$4.879195005460081e+39M$6.4K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: HCLC vs NOBL ($10,000, DRIP)

YearHCLC PortfolioHCLC Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,120$420.00+$200.00M → HCLC
2$3,738,731,768,458$3,738,517,757,009.35$12,357$458.31+$3738731.76M → HCLC
3$65,315,062,866,930,490$65,311,062,423,938,240.00$13,721$499.76+$65315062866.92M → HCLC
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$15,227$544.58+$1066400830062625.00M → HCLC
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$16,885$593.02+$16272182796453826560.00M → HCLC
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$18,713$645.34+$2.3205424011366188e+23M → HCLC
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$20,724$701.81+$3.0927990661046884e+27M → HCLC
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$22,938$762.73+$3.8524105697352695e+31M → HCLC
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$25,372$828.41+$4.484688260147987e+35M → HCLC
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$28,047$899.19+$4.879226400974806e+39M → HCLC

HCLC vs NOBL: Complete Analysis 2026

HCLC — Stock

Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.

Full HCLC Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →
📬

Get this HCLC vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HCLC vs SCHDHCLC vs JEPIHCLC vs OHCLC vs KOHCLC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.